167 related articles for article (PubMed ID: 17045271)
21. Circulating IgA-Lp complexes in Watanabe heritable hyperlipidemic and cholesterol fed NZW rabbits.
Beaumont JL; Vivier P
Atherosclerosis; 1990 Jun; 82(3):227-35. PubMed ID: 2375787
[TBL] [Abstract][Full Text] [Related]
22. Lipid-lowering and antiatherosclerotic effect of NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits.
Suzuki H; Yamazaki H; Aoki T; Kojima J; Tamaki T; Sato F; Kitahara M; Saito Y
Arzneimittelforschung; 2000 Nov; 50(11):995-1003. PubMed ID: 11187394
[TBL] [Abstract][Full Text] [Related]
23. ApoVLDL of the Watanabe Heritable Hyperlipidemic rabbit and the cholesterol-fed rabbit.
Wakasugi T; Mabuchi H; Sakai Y; Sakai T; Yoshimura A; Watanabe A; Koizumi J; Miyamoto S; Takeda R; Watanabe Y
J Lipid Res; 1984 Mar; 25(3):246-53. PubMed ID: 6726079
[TBL] [Abstract][Full Text] [Related]
24. Natural history of atherosclerosis and hyperlipidemia in heterozygous WHHL (WHHL-Hh) rabbits. II. Morphologic evaluation of spontaneously occurring aortic and coronary lesions.
Esper E; Runge WJ; Gunther R; Buchwald H
J Lab Clin Med; 1993 Jan; 121(1):103-10. PubMed ID: 8426070
[TBL] [Abstract][Full Text] [Related]
25. Nifedipine suppressed atherosclerosis in cholesterol-fed rabbits but not in Watanabe heritable hyperlipidemic rabbits.
Watanabe N; Ishikawa Y; Okamoto R; Watanabe Y; Fukuzaki H
Artery; 1987; 14(5):283-94. PubMed ID: 3662844
[TBL] [Abstract][Full Text] [Related]
26. Microcytic thrombocytosis, small megakaryocytes, platelet lipids and hyperreactivity to collagen, lymphocytopenia, eosinophilia, and low blood volume in genetically hyperlipidemic rabbits.
Ebbe S; Dalal K; Forte T; Tablin F
Exp Hematol; 1992 May; 20(4):486-93. PubMed ID: 1568466
[TBL] [Abstract][Full Text] [Related]
27. The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (I) - Contribution to the Elucidation of the Pathophysiology of Human Hypercholesterolemia and Coronary Heart Disease.
Shiomi M
J Atheroscler Thromb; 2020 Feb; 27(2):105-118. PubMed ID: 31748469
[TBL] [Abstract][Full Text] [Related]
28. Unstable coronary plaques and cardiac events in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits: questions and quandaries.
Shiomi M; Fan J
Curr Opin Lipidol; 2008 Dec; 19(6):631-6. PubMed ID: 18957890
[TBL] [Abstract][Full Text] [Related]
29. Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein[a].
Fan J; Challah M; Shimoyamada H; Shiomi M; Marcovina S; Watanabe T
J Lipid Res; 2000 Jun; 41(6):1004-12. PubMed ID: 10828093
[TBL] [Abstract][Full Text] [Related]
30. Different role of macrophages and vascular smooth muscle cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic (WHHL) rabbit between aorta and coronary artery.
Ohtani H; Shingu T; Chayama K; Hayashi K
Hiroshima J Med Sci; 2008 Jun; 57(2):53-60. PubMed ID: 18717187
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II Destabilizes Coronary Plaques in Watanabe Heritable Hyperlipidemic Rabbits.
Li S; Wang YN; Niimi M; Ning B; Chen Y; Kang D; Wang Z; Yu Q; Waqar AB; Liu E; Zhang J; Shiomi M; Chen YE; Fan J
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):810-816. PubMed ID: 26988589
[TBL] [Abstract][Full Text] [Related]
32. [Lipoprotein(a) as a biochemical marker of coronary atherosclerosis].
Ezhov MV; Afanas'ev OI; Benevolenskaia GF; Savchenko AP; Liakishev AA; Pokrovskiĭ SN
Ter Arkh; 1997; 69(9):31-4. PubMed ID: 9411822
[TBL] [Abstract][Full Text] [Related]
33. Effects of NO-1886, a lipoprotein lipase promoting agent, on homozygous and heterozygous Watanabe heritable hyperlipidaemic rabbits.
Tsutsumi K; Inoue Y; Murase T
Arzneimittelforschung; 2000 Feb; 50(2):118-21. PubMed ID: 10719613
[TBL] [Abstract][Full Text] [Related]
34. Lipoprotein(a) in cerebrovascular and coronary atherosclerosis.
Nomura S
Hiroshima J Med Sci; 1995 Dec; 44(4):133-9. PubMed ID: 8857237
[TBL] [Abstract][Full Text] [Related]
35. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits.
Watanabe Y; Ito T; Shiomi M; Tsujita Y; Kuroda M; Arai M; Fukami M; Tamura A
Biochim Biophys Acta; 1988 Jun; 960(3):294-302. PubMed ID: 3132979
[TBL] [Abstract][Full Text] [Related]
36. Social experience influences hypothalamic oxytocin in the WHHL rabbit.
Paredes J; Szeto A; Levine JE; Zaias J; Gonzales JA; Mendez AJ; Llabre MM; Schneiderman N; McCabe PM
Psychoneuroendocrinology; 2006 Oct; 31(9):1062-75. PubMed ID: 16963189
[TBL] [Abstract][Full Text] [Related]
37. Measurement by quantitative reverse transcription-polymerase chain reaction of the levels of tumor necrosis factor alpha mRNA in atherosclerotic arteries in Watanabe heritable hyperlipidemic rabbits.
Lei X; Buja LM
Lab Invest; 1996 Jan; 74(1):136-45. PubMed ID: 8569176
[TBL] [Abstract][Full Text] [Related]
38. Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins.
Shiomi M; Koike T; Ito T
Atherosclerosis; 2013 Nov; 231(1):39-47. PubMed ID: 24125408
[TBL] [Abstract][Full Text] [Related]
39. Aortic response to relaxing agents in Watanabe heritable hyperlipidemic (WHHL) rabbits of different age.
Chinellato A; Banchieri N; Pandolfo L; Ragazzi E; Froldi G; Norido F; Caparrotta L; Fassina G
Atherosclerosis; 1991 Aug; 89(2-3):223-30. PubMed ID: 1793450
[TBL] [Abstract][Full Text] [Related]
40. Gradient echo MRI characterization of development of atherosclerosis in the abdominal aorta in Watanabe Heritable Hyperlipidemic rabbits.
Wang YX; Kuribayashi H; Wågberg M; Holmes AP; Tessier JJ; Waterton JC
Cardiovasc Intervent Radiol; 2006; 29(4):605-12. PubMed ID: 16729232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
